The impact of beta blockers on survival outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors

被引：0
|
作者：
Oh, Michael [1 ]
Oh, Michael [1 ]
Guzner, Alex [1 ]
Wainwright, Derek [1 ]
Mohindra, Nisha [1 ]
Chae, Young Kwang [1 ]
Behdad, Amir [1 ]
Villaflor, Victoria [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P635
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Oh, Michael S.
    Guzner, Alex
    Wainwright, Derek A.
    Mohindra, Nisha A.
    Chae, Young K.
    Behdad, Amir
    Villaflor, Victoria M.
    CLINICAL LUNG CANCER, 2021, 22 (01) : E57 - E62
  • [2] Comments on 'The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors'
    Takada, Kazuki
    Takamori, Shinkichi
    Miura, Naoko
    Shikada, Yasunori
    Shimokawa, Mototsugu
    CLINICAL LUNG CANCER, 2022, 23 (03) : E174 - E175
  • [3] Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
    Zhang, Tongtong
    Li, Shuluan
    Chang, Jianhua
    Qin, Yan
    Li, Chao
    BMC CANCER, 2023, 23 (01)
  • [4] Impact of BMI on the survival outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
    Tongtong Zhang
    Shuluan Li
    Jianhua Chang
    Yan Qin
    Chao li
    BMC Cancer, 23
  • [5] The impact of perioperative sufentanil administration on cardiovascular outcomes in non-small cell lung cancer patients treated with immune checkpoint inhibitors
    毛松松
    陈解元
    马珏
    张光燕
    侯兴华
    农丽丹
    崔建修
    SouthChinaJournalofCardiology, 2024, 25 (01) : 21 - 28
  • [6] Survival of patients with non-small cell lung cancer having leptomeningeal metastases treated with immune checkpoint inhibitors
    Hendriks, Lizza E. L.
    Bootsma, Gerben
    Mourlanette, Jean
    Henon, Clemence
    Mezquita, Laura
    Ferrara, Roberto
    Audigier-Valette, Clarisse
    Mazieres, Julien
    Lefebvre, Corentin
    Duchemann, Boris
    Cousin, Sophie
    le Pechoux, Cecile
    Botticella, Angela
    De Ruysscher, Dirk
    Dingemans, Anne-Marie C.
    Besse, Benjamin
    EUROPEAN JOURNAL OF CANCER, 2019, 116 : 182 - 189
  • [7] The Impact of Inflammatory Serum Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
    Cipriano, E.
    Magalhaes, H.
    Estevinho, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S255 - S255
  • [8] Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancer
    Sumodhee, S.
    Guo, L.
    Bouhlel, L.
    Picard, A.
    Otto, J.
    Naghavi, A. O.
    Richier, Q.
    Levy, A.
    Bondiau, P-Y
    Poudenx, M.
    Passeron, T.
    Lacour, J-P
    Montaudie, H.
    Doyen, J.
    CANCER RADIOTHERAPIE, 2022, 26 (08): : 1045 - 1053
  • [9] CNS Metastasis Negatively Impact Overall Survival of Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immune Checkpoint Inhibitors
    Souza, C.
    Spina Donadio, M. D.
    Simoes, M. F.
    Maciel Santana, D.
    Barbosa De Medeiros, M. F.
    Mendes Gomes, L. B.
    Petrocchi Corassa, M.
    De Freitas, H.
    De Lima, V. C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S289 - S289
  • [10] Incidence of Cardiotoxicity in Patients Treated for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Carpenter, I. N.
    Brice, K. B.
    Walker, D.
    Dumais, K.
    Alvarez, A. M.
    Cohen, N. S.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S629 - S629
12345